Sources
Accelerator takes a broad approach to identifying tomorrow’s technologies today. Through the company’s investors’ and ISB’s extensive network of consultants, advisors, scientific and medical opinion leaders and contacts within the financial community, Accelerator is extremely well positioned to identify promising technologies that have the potential to become critical components of the future in medical and healthcare. These technologies may be found within academia, the biotechnology and biopharmaceutical industries, or private innovators and talented individuals.

Accelerator welcomes unsolicited submissions of new ideas.

While Accelerator technologies emerge from different sources 3 traits each company have in common are:

• Innovative ideas – technologies that are based on new insights and novel approaches that enable the development of innovative products;
• Disruptive technologies – novel approaches that enable a paradigm shift in medicine and healthcare; and,
• Transforming potential - approaches that have the potential to transform medicine and healthcare rather than incremental improvements

However all Accelerator companies have one critical trait in common:

• Milestone-driven development pathways – a clear set of development objectives designed to advance novel technologies rapidly from discovery to a proof-of-concept development stage that would support further financing